Daniel Vitt
Board Member
Immunic, Inc. (IMUX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Daniel Vitt
Daniel Vitt is recorded as Board Member at Immunic, Inc. (IMUX). Immunic, Inc. reported in an 8-K filed August 11, 2026 that Daniel Vitt was appointed Founder and Chair of the Company's Scientific Advisory Board, effective August 7, 2026. Immunic, Inc. reported in an 8-K filed May 27, 2026 that Daniel Vitt resigned as Chief Executive Officer, effective June 1, 2026. Immunic, Inc. reported in an 8-K filed January 5, 2026 that Daniel Vitt was appointed Board Member, effective January 1, 2026. Equibles holds 4 filed executive changes naming Daniel Vitt; each is listed under recent activity with its source filing.
“Your title will be changed on the date of this Agreement to Founder and Chair of the Company's Scientific Advisory Board (the "SAB").”
“On May 22, 2026, Daniel Vitt, resigned as the Chief Executive Officer of the Company, effective June 1, 2026.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Immunic, Inc. (IMUX)
SEC 8-K
Current2026-08-07–present
-
Current
2026-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Immunic, Inc.
Other people whose current roles at this company are on record from its filings.
- Dr. Daniel Vitt CEO
- Duane D. Nash CEO
- Duane Nash CEO
- Erik Lundgren CEO, Board Member
- Russell J. Cox CEO
- Michael W. Bonney Chairman
- Simona Skerjanec Chairman, Board Member
- Glenn Whaley CFO
- Jason Tardio COO
- Inderpal Singh General Counsel
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.